|
Message from the President
Dear ACDS Member,
I love the professional and personal relationships that I have forged as a member of the American Contact Dermatitis Society. I love what my ACDS colleagues and mentors have taught me over the years. What do you love about the ACDS? How does our Society make your week better?
Speaking of your week, one of our colleagues, Dr. Andrew Scheman, developed and managed a product that many of us use every week, the Contact Allergen Management Program (CAMP). In recognition and appreciation of his exemplary service to ACDS and CAMP, Dr. Scheman has been named an Honorary Member of the ACDS! Please join me in congratulating Dr. Scheman. We truly appreciate his contributions to the Society.
Healthcare for and research specific to diverse populations and support for our under-represented in medicine colleagues and trainees is vital. For this reason, we are in the process of developing the ACDS Diversity, Equity and Healthcare Disparities Task Force. Watch your inboxes for an opportunity to volunteer!
As previously announced, the ACDS Fall Meeting has been postponed to October 1-2, 2021, in Philadelphia, PA. Our Co-Chairs, Drs. Jeff Yu and Erin Warshaw, have an excellent agenda planned. Please watch for more information in the coming months. I am ever hopeful that I will see your shining faces in Philly.
ACDS has developed virtual events to help our members stay connected, and they are pretty fantastic! Our inaugural event was held on June 11th, featuring Dr. Jenny Murase, Dr. Erin Warshaw and Dr. Jeff Yu. Our upcoming events include Virtual Journal Club and an interactive Board Review session for our resident members. Be sure to check out the specifics below.
It is my hope that you, our members, have had every opportunity to stay healthy and happy during this unprecedented time.
Yours in Patch Testing,
Facebook: @ACDSDermatitis @DermatitisJournal
Instagram: ACDS_Dermatitis
Twitter: @ACDS_Dermatitis @dermatitisJrnl
|
Inside this Issue
|
Nominate a Future Leader! - Accepting Nominations August 17 – October 8, 2020
The ACDS Board of Directors is the fiduciary body, responsible for governance of the ACDS and stewardship of its assets. It is empowered to act on behalf of the membership within the framework of the organization's bylaws and is legally, ethically, and morally responsible for performing its functions.
Beginning August 17th, nominations will be accepted for the following positions:
- President-Elect (1 opening)
- Board of Directors (3 openings)
All ACDS members are encouraged to nominate a fellow member of the Society for election to the board of directors. Self-nominations are allowed and encouraged. Find out more information by clicking here.
Back to the Top
ACDS Diversity, Equity and Healthcare Disparities Task Force - Volunteer!
Health care and research specific to diverse populations and support for our under-represented medicine colleagues and trainees is vital. For this reason, we are in the process of developing the ACDS Diversity, Equity and Healthcare Disparities Task Force. We are looking for one Co-Chair and several additional Task Force Members to help brainstorm ideas. If this is something that interests you, please complete the below survey by Friday, August 7th.
Please let us know if you have any questions or additional suggestions by emailing info@contactderm.org.
Back to the Top
 Update
Congratulations to Dr. Ponciano Cruz, Dermatitis Editor-in-Chief, and his team for obtaining a 3.988 impact factor, the highest ever achieved in the journal’s history. Dermatitis is now ranked 8th out of 68 journals in dermatology.
The Dermatitis Journal is the official Journal of the ACDS and is published six times per year. Dermatitis focuses on contact, atopic, occupational, and drug dermatitis, and welcomes manuscript submissions in these fields, with emphasis on reviews, studies, reports, and letters. We invite you to find out more information about publishing within the Dermatitis Journal by clicking here.
Back to the Top
ACDS AMA and Health Policy Committee Update
The American Medical Association held a virtual meeting on June 7, 2020. Unlike prior meetings, specific health policy was not crafted at this meeting. Elections were held and there was an excellent presentation from Immediate Past President, Patrice Harris on systemic racism. The current AMA president Susan R. Bailey, MD, was inaugurated as the 175th AMA President. Dr. Bailey is an allergist from Fort Worth, Texas, which will allow for future opportunities to address interests common to our sub-specialty of dermatitis. The next AMA meeting, scheduled for November 2020, will also be virtual. Although the format will be different from prior live meetings, there will be robust discussions on health policy. ACDS is still on track to become a full voting society member at the AMA House of Delegates in November 2021.
During the public health emergency, which was recently extended for another 90 days by the federal government, the AMA and the AAD/A have been advocating for issues of great importance to us. These issues include the following:
- Continued safe use of teledermatology with choice of platforms and payment transparency.
- Immunity from medical liability in the peri-pandemic period.
- Relief programs including the provider relief funds and the Paycheck Protection Programs.
- Access to Personal Protective Equipment.
- Administrative Relief, such as eliminating penalties associated with MIPS in Y 2020.
- Suspension of the 2% sequester on payment received in Medicare
Bruce A. Brod, MD MHCI FAAD
Chair, ACDS AMA and Health Policy Committee
Back to the Top
ACDS Member Highlight
ACDS is pleased to announce that Dr. Andrew Scheman has been awarded Honorary Membership status within the Society for his vast contributions to CAMP and contact dermatitis.
Dr. Andrew Scheman is a Professor of Clinical Dermatology at Northwestern University Feinberg School of Medicine. A member of the ACDS since 1992, Dr. Scheman was the director of the ACDS Contact Allergy Management Program (CAMP) from 2012 to 2019. In 2015, he received the Alexander A. Fisher Lecture Award and gave the “Contact Allergy Cross-Reactors” lecture at the ACDS 26th Annual Meeting. In addition, Dr. Scheman has served on the ACDS Board of Directors and on 10 ACDS committees.
Dr. Scheman has a strong interest in advancing studies on contact allergy alternatives. He founded the American Contact Alternatives Group (ACAG) and is the first contact allergy alternatives section editor for Dermatitis. He has authored 100 peer reviewed publications including eight editions of Pocket Guide to Medications Used in Dermatology and a chapter in the current edition of Fisher’s Contact Allergy.
Join us in thanking Dr. Scheman for his years of dedication to contact dermatitis and the ACDS.
Back to the Top
Education and Research Awards
The ACDS is committed to advancing the care and understanding of dermatitis and allergy through the promotion of education, research and advocacy. As part of this initiative, ACDS offers education awards to help encourage research in these areas.
Clinical Research Award for young investigators in the sub-specialty
Mentoring Award to nurture young leaders in the sub-specialty
Mid-Career Award provides financial support to defray the cost of acquiring specific skills and knowledge to enhance professional development
Outcomes Research Award to establish the value of expert specialist evaluation and management of chronic dermatitis
For more information or to apply for an award, click here.
Congratulations to the below 2020 Clinical Research Award Winners for the spring award cycle.
2020 Clinical Research Award Winners
- Vaibhav Garg - “Characterizing Patterns of Allergy in African American Allergic Contact Dermatitis Patients”
- Lindsey Voller - “Investigation of Commercial Essential Oils for Formaldehyde Content”
Back to the Top
Upcoming ACDS Events
Thursday, August 20, 2020
Time: 8:30pm ET | 7:30pm CT | 6:30pm MT | 5:30pm PT
Registration: FREE! - Registration required below
A Zoom link will be provided to all registered attendees prior to the event.
Objective: Recognize and review the top four 2019 ACDS Dermatitis Articles of the Year as presented by the original authors. Each author will present a summary of their article and be available for a Q&A session at the end of the session. Stay connected with your colleagues and inspire interest in contact dermatitis.
To register, please click here.
Back to the Top
Thursday, September 17, 2020
Time: 8:30pm ET | 7:30pm CT | 6:30pm MT | 5:30pm PT
Registration: FREE! - Registration required below
A Zoom link will be provided to all registered attendees prior to the event.
Target Audience: Residents and recent graduates, who are studying for their boards
Objective: Provide dermatology residents with an interactive, board-focused review of dermatology to aid participants in preparation for the American Board of Dermatology’s Certification Exam.
To register, please click here.
Back to the Top
Access the ACDS 31st Annual Online educational content now through the end of the year and watch at your own pace. If you have any questions please email us. Access to this educational content requires registration. Register today!
Online Registration Fees
ACDS Members - $100
Non-Members - $125
Residents - Free
Sponsorship Support
The American Contact Dermatitis Society wishes to thank the following sponsors for supporting the Society and this online experience.
Back to the Top
Back to the Top
Back to the Top
Call for Applications
Contact Dermatitis, Editor-in-Chief 2021-2025
John Wiley and Sons is seeking a new Editor-in-Chief for Contact Dermatitis (COD) to serve an initial five-year term commencing 1st January 2021 to 31st December 2025. The Editor-in-Chief will be an innovative and ethical clinician with a distinguished record of accomplishment in various aspect of environmental dermatitis research.
He/she will be capable of developing and executing a highly competitive strategy for the Journal and be able to lead the editorial team. The Editor-in-Chief will appoint a team of Associate Editors, who will support him/her.
The post carries an annual stipend. The application deadline is August 30, 2020. Interviews will take place in September 2020.
For more information click here.
Please send in your application by email to Lisbeth Cranfield, Senior Journal Publishing Manager at lbc@wiley.com by August 30th, 2020.
Back to the Top
Follow ACDS on 
Back to the Top
|
